Biologics to 2006 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends
Released on = April 20, 2007, 4:17 am
Press Release Author = Bharat Book Bureau
Industry = Marketing
Press Release Summary = Biologics to 2006 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends : US demand for biologics will grow over 11 percent annually through 2006, driven by new product introductions that enable drug researchers to develop better medicines.
Press Release Body = Biologics to 2006 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends
Biologics to 2006 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends : US demand for biologics will grow over 11 percent annually through 2006, driven by new product introductions that enable drug researchers to develop better medicines. Monoclonal antibodies will grow the fastest while recombinant proteins become the top-selling segment. Vaccines will offer the best opportunities among conventional types.
This study analyzes $32.7 billion US market for commercially valuable compounds derived from human, animal and microbial sources. It presents historical (1992, 1996, 2001) data and forecasts to 2006 and 2011 by type (e.g., blood and derivatives, protein drugs, vaccines, reagents, hormones, interferons, biological response modifiers, recombinant enzymes, monoclonal antibodies); by raw material, by application and by market.
The study also examines the market environment, details industry structure and market share, and profiles 45 competitors including Amgen, Johnson & Johnson, Aventis, Eli Lilly, Genentech, Wyeth, Baxter, GlaxoSmithKline, Schering-Plough, Merck, Biogen, Chiron, MedImmune, and Genzyme
For more information, Please visit : http://www.bharatbook.com/detail.asp?id
2012
